Adoptive transfer of activated marrow-infiltrating lymphocytes induces measurable antitumor immunity in the bone marrow in multiple myeloma

Science Translational Medicine

Volumn 7, Issue 288, 2015, Pages

  Noonan, Kimberly A ^a   Huff, Carol A ^a   Davis, Janice ^a   Lemas, M Victor ^a   Fiorino, Susan ^a   Bitzan, Jeffrey ^a   Ferguson, Anna ^a   Emerling, Amy ^a   Luznik, Leo ^a   Matsui, William ^a   Powell, Jonathan ^a   Fuchs, Ephraim ^a   Rosner, Gary L ^a   Epstein, Caroline ^a   Rudraraju, Lakshmi ^a   Ambinder, Richard F ^a   Jones, Richard J ^a   Pardoll, Drew ^a   Borrello, Ivan ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; MYELOABLATIVE AGENT;

ADOPTIVE TRANSFER; ADULT; AGED; ARTICLE; BONE MARROW; CANCER SURVIVAL; CELL EXPANSION; CELL THERAPY; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INTERFERON PRODUCTION; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; MALE; MARROW INFILTRATING LYMPHOCYTE; MEMORY T LYMPHOCYTE; MULTIPLE MYELOMA; PHASE 1 CLINICAL TRIAL; PHENOTYPE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; SURVIVAL TIME; T LYMPHOCYTE SUBPOPULATION; THERAPY EFFECT; TREATMENT OUTCOME; TUMOR MICROENVIRONMENT; ADOPTIVE IMMUNOTHERAPY; ADVERSE EFFECTS; CELL CULTURE; CELL SEPARATION; CLINICAL TRIAL; DISEASE FREE SURVIVAL; FEASIBILITY STUDY; IMMUNOLOGY; KAPLAN MEIER METHOD; MARYLAND; MIDDLE AGED; MORTALITY; PROCEDURES; REMISSION; T LYMPHOCYTE; TIME FACTOR; TRANSPLANTATION; TUMOR ASSOCIATED LEUKOCYTE;

ADULT; AGED; BALTIMORE; BONE MARROW; CELL SEPARATION; CELLS, CULTURED; DISEASE-FREE SURVIVAL; FEASIBILITY STUDIES; FEMALE; HUMANS; IMMUNOTHERAPY, ADOPTIVE; KAPLAN-MEIER ESTIMATE; LYMPHOCYTE ACTIVATION; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; MULTIPLE MYELOMA; MYELOABLATIVE AGONISTS; REMISSION INDUCTION; T-LYMPHOCYTES; TIME FACTORS; TREATMENT OUTCOME; TUMOR MICROENVIRONMENT;

EID: 84929815755     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.aaa7014     Document Type: Article

References (36)

1. M. Attal, J. L. Harousseau, A. M. Stoppa, J. J. Sotto, J. G. Fuzibet, J. F. Rossi, P. Casassus, H. Maisonneuve, T. Facon, N. Ifrah, C. Payen, R. Bataille, A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome. N. Engl. J. Med. 335, 91-97 (1996).
2. I. Borrello, E. M. Sotomayor, F. M. Rattis, S. K. Cooke, L. Gu, H. I. Levitsky, Sustaining the graft-versus-tumor effect through posttransplant immunization with granulocyte-macrophage colony-stimulating factor (GM-CSF)-producing tumor vaccines. Blood 95, 3011-3019 (2000).
3. A. P. Rapoport, E. A. Stadtmauer, N. Aqui, A. Badros, J. Cotte, L. Chrisley, E. Veloso, Z. Zheng, S. Westphal, R. Mair, N. Chi, B. Ratterree, M. F. Pochran, S. Natt, J. Hinkle, C. Sickles, A. Sohal, K. Ruehle, C. Lynch, L. Zhang, D. L. Porter, S. Luger, C. Guo, H. B. Fang, W. Blackwelder, K. Hankey, D. Mann, R. Edelman, C. Frasch, B. L. Levine, A. Cross, C. H. June, Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer. Nat. Med. 11, 1230-1237 (2005).
4. W. Dummer, A. G. Niethammer, R. Baccala, B. R. Lawson, N. Wagner, R. A. Reisfeld, A. N. Theofilopoulos, T cell homeostatic proliferation elicits effective antitumor autoimmunity. J. Clin. Invest. 110, 185-192 (2002).
5. L. F. Porrata, M. A. Gertz, D. J. Inwards, M. R. Litzow, M. Q. Lacy, A. Tefferi, D. A. Gastineau, A. Dispenzieri, S. M. Ansell, I. N. Micallef, S. M. Geyer, S. N. Markovic, Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma. Blood 98, 579-585 (2001).
6. C. Joao, L. F. Porrata, D. J. Inwards, S. M. Ansell, I. N. Micallef, P. B. Johnston, D. A. Gastineau, S. N. Markovic, Early lymphocyte recovery after autologous stem cell transplantation predicts superior survival in mantle-cell lymphoma. Bone Marrow Transplant. 37, 865-871 (2006).
7. L. F. Porrata, M. R. Litzow, A. Tefferi, L. Letendre, S. Kumar, S. M. Geyer, S. N. Markovic, Early lymphocyte recovery is a predictive factor for prolonged survival after autologous hematopoietic stem cell transplantation for acute myelogenous leukemia. Leukemia 16, 1311-1318 (2002).
8. L. F. Porrata, D. J. Inwards, S. M. Ansell, I. N. Micallef, P. B. Johnston, D. A. Gastineau, M. R. Litzow, J. L. Winters, S. N. Markovic, Early lymphocyte recovery predicts superior survival after autologous stem cell transplantation in non-Hodgkin lymphoma: A prospective study. Biol. Blood Marrow Transplant. 14, 807-816 (2008).
9. B. L. Levine, W. B. Bernstein, M. Connors, N. Craighead, T. Lindsten, C. B. Thompson, C. H. June, Effects of CD28 costimulation on long-term proliferation of CD4+ T cells in the absence of exogenous feeder cells. J. Immunol. 159, 5921-5930 (1997).
10. S. A. Rosenberg, N. P. Restifo, J. C. Yang, R. A. Morgan, M. E. Dudley, Adoptive cell transfer: A clinical path to effective cancer immunotherapy. Nat. Rev. Cancer 8, 299-308 (2008).
11. L. T. Nguyen, P. H. Yen, J. Nie, N. Liadis, D. Ghazarian, A. Al-Habeeb, A. Easson, W. Leong, J. Lipa, D. McCready, M. Reedijk, D. Hogg, A. M. Joshua, I. Quirt, H. Messner, P. Shaw, M. Crump, E. Sharon, P. S. Ohashi, Expansion and characterization of human melanoma tumor-infiltrating lymphocytes (TILs). PLOS One 5, e13940 (2010).
12. M. Feuerer, P. Beckhove, L. Bai, E. F. Solomayer, G. Bastert, I. J. Diel, C. Pedain, M. Oberniedermayr, V. Schirrmacher, V. Umansky, Therapy of human tumors in NOD/SCID mice with patient-derived reactivated memory T cells from bone marrow. Nat. Med. 7, 452-458 (2001).
13. + T cell survival but not for antigen proliferation. Nat. Immunol. 1, 54-58 (2000).
14. + T cells. Immunity 22, 259-270 (2005).
15. T. C. Becker, S. M. Coley, E. J. Wherry, R. Ahmed, Bone marrow is a preferred site for homeostatic proliferation of memory CD8 T cells. J. Immunol. 174, 1269-1273 (2005).
16. K. Noonan, W. Matsui, P. Serafini, R. Carbley, G. Tan, J. Khalili, M. Bonyhadi, H. Levitsky, K. Whartenby, I. Borrello, Activated marrow-infiltrating lymphocytes effectively target plasma cells and their clonogenic precursors. Cancer Res. 65, 2026-2034 (2005).
17. M. Feuerer, P. Beckhove, N. Garbi, Y. Mahnke, A. Limmer, M. Hommel, G. J. Hammerling, B. Kyewski, A. Hamann, V. Umansky, V. Schirrmacher, Bone marrow as a priming site for T-cell responses to blood-borne antigen. Nat. Med. 9, 1151-1157 (2003).
18. I. Petit, M. Szyper-Kravitz, A. Nagler, M. Lahav, A. Peled, L. Habler, T. Ponomaryov, R. S. Taichman, F. Arenzana-Seisdedos, N. Fujii, J. Sandbank, D. Zipori, T. Lapidot, G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat. Immunol. 3, 687-694 (2002).
19. +-selected hematopoietic cell transplantation. Blood 102, 2004-2013 (2003).
20. A. P. Rapoport, E. A. Stadtmauer, N. Aqui, D. Vogl, A. Chew, H. B. Fang, S. Janofsky, K. Yager, E. Veloso, Z. Zheng, T. Milliron, S. Westphal, J. Cotte, H. Huynh, A. Cannon, S. Yanovich, G. Akpek, M. Tan, K. Virts, K. Ruehle, C. Harris, S. Philip, R. H. Vonderheide, B. L. Levine, C. H. June, Rapid immune recovery and graft-versus-host disease-like engraftment syndrome following adoptive transfer of costimulated autologous T cells. Clin. Cancer Res. 15, 4499-4507 (2009).
21. A. P. Rapoport, N. A. Aqui, E. A. Stadtmauer, D. T. Vogl, H. B. Fang, L. Cai, S. Janofsky, A. Chew, J. Storek, G. Akpek, A. Badros, S. Yanovich, M. T. Tan, E. Veloso, M. F. Pasetti, A. Cross, S. Philip, H. Murphy, R. Bhagat, Z. Zheng, T. Milliron, J. Cotte, A. Cannon, B. L. Levine, R. H. Vonderheide, C. H. June, Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination on the basis of hTERT and survivin after ASCT for myeloma. Blood 117, 788-797 (2011).
22. + T cells can mediate antileukemic activity and persist in post-transplant patients. Sci. Transl. Med. 5, 174ra127 (2013).
23. M. R. Betts, J. M. Brenchley, D. A. Price, S. C. De Rosa, D. C. Douek, M. Roederer, R. A. Koup, Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J. Immunol. Methods 281, 65-78 (2003).
24. K. Noonan, L. Rudraraju, A. Ferguson, A. Emerling, M. F. Pasetti, C. A. Huff, I. Borrello, Lenalidomideinduced immunomodulation in multiple myeloma: Impact on vaccines and antitumor responses. Clin. Cancer Res. 18, 1426-1434 (2012).
25. F. Di Rosa, R. Pabst, The bone marrow: A nest for migratory memory T cells. Trends Immunol. 26, 360-366 (2005).
26. + T cells derived from central memory cells establishes persistent T cell memory in primates. J. Clin. Invest. 118, 294-305 (2008).
27. + T cells confer superior antitumor immunity compared with effector memory T cells. Proc. Natl. Acad. Sci. U.S.A. 102, 9571-9576 (2005).
28. E. Lugli, M. H. Dominguez, L. Gattinoni, P. K. Chattopadhyay, D. L. Bolton, K. Song, N. R. Klatt, J. M. Brenchley, M. Vaccari, E. Gostick, D. A. Price, T. A. Waldmann, N. P. Restifo, G. Franchini, M. Roederer, Superior T memory stem cell persistence supports long-lived T cell memory. J. Clin. Invest. 123, 594-599 (2013).
29. S.A.Grupp,M.Kalos,D.Barrett,R.Aplenc,D.L.Porter,S.R.Rheingold,D.T.Teachey,A.Chew, B. Hauck, J. F. Wright, M. C. Milone, B. L. Levine, C. H. June, Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. N. Engl. J. Med. 368,1509-1518 (2013).
30. M. V. Maus, S. A. Grupp, D. L. Porter, C. H. June, Antibody-modified T cells: CARs take the front seat for hematologic malignancies. Blood 123, 2625-2635 (2014).
31. M. L. Davila, I. Riviere, X. Wang, S. Bartido, J. Park, K. Curran, S. S. Chung, J. Stefanski, O. Borquez-Ojeda, M. Olszewska, J. Qu, T. Wasielewska, Q. He, M. Fink, H. Shinglot, M. Youssif, M. Satter, Y. Wang, J. Hosey, H. Quintanilla, E. Halton, Y. Bernal, D. C. Bouhassira, M. E. Arcila, M. Gonen, G. J. Roboz, P. Maslak, D. Douer, M. G. Frattini, S. Giralt, M. Sadelain, R. Brentjens, Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia. Sci. Transl. Med. 6, 224ra225 (2014).
32. J. Chu, Y. Deng, D. M. Benson, S. He, T. Hughes, J. Zhang, Y. Peng, H. Mao, L. Yi, K. Ghoshal, X. He, S. M. Devine, X. Zhang, M. A. Caligiuri, C. C. Hofmeister, J. Yu, CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo antitumor activity against human multiple myeloma. Leukemia 28, 917-927 (2014).
33. R. O. Carpenter, M. O. Evbuomwan, S. Pittaluga, J. J. Rose, M. Raffeld, S. Yang, R. E. Gress, F. T. Hakim, J. N. Kochenderfer, B-cell maturation antigen is a promising target for adoptive T-cell therapy of multiple myeloma. Clin. Cancer Res. 19, 2048-2060 (2013).
34. L. Holmberg, K. Kikuchi, T. A. Gooley, K. M. Adams, D. M. Hockenbery, M. E. Flowers, H. G. Schoch, W. Bensinger, G. B. McDonald, Gastrointestinal graft-versus-host disease in recipients of autologous hematopoietic stem cells: Incidence, risk factors, and outcome. Biol. Blood Marrow Transplant. 12, 226-234 (2006).
35. J. J. Lahuerta, M. V. Mateos, J. Martinez-Lopez, L. Rosinol, A. Sureda, J. de la Rubia, J. Garcia-Larana, R. Martinez-Martinez, M. T. Hernandez-Garcia, D. Carrera, J. Besalduch, F. de Arriba, J. M. Ribera, L. Escoda, B. Hernandez-Ruiz, J. Garcia-Frade, C. Rivas-Gonzalez, A. Alegre, J. Blade, J. F. San Miguel, Influence of pre- and post-transplantation responses on outcome of patients with multiple myeloma: Sequential improvement of response and achievement of complete response are associated with longer survival. J. Clin. Oncol. 26, 5775-5782 (2008).
36. P. Sonneveld, H. Goldschmidt, L. Rosinol, J. Blade, J. J. Lahuerta, M. Cavo, P. Tacchetti, E. Zamagni, M. Attal, H. M. Lokhorst, A. Desai, A. Cakana, K. Liu, H. van de Velde, D. L. Esseltine, P. Moreau, Bortezomib-based versus nonbortezomib-based induction treatment before autologous stem-cell transplantation in patients with previously untreated multiple myeloma: A meta-analysis of phase III randomized, controlled trials. J. Clin. Oncol. 31, 3279-3287 (2013). Downloaded from stm.sciencemag.org on May 21, 2015